Polycyclic Aromatic Hydrocarbons: Multiple Metabolic Pathways and the DNA Lesions Formed

The Chemical Biology of DNA Damage

Volumn , Issue , 2010, Pages 131-155

  Penning, Trevor M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Benzo a pyrene; Diol epoxide; DNA lesion; O quinone; Polycyclic aromatic hydrocarbon; Radical cation

Indexed keywords

EID: 84867965856     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527630110.ch6     Document Type: Chapter

References (118)

1. Straff, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., and Cogliano, V. (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Policy Watch. Lancet Oncol., 6, 931-932.
2. Beak, S.O., Field, R.A., Goldstein, M.E., Kirk, P.W., Lester, J.N., and Perry, R. (1991) A review of atmospheric polycyclic aromatic hydrocarbons: sources, fate and behavior. Water Air Soil Pollut., 60, 279-300.
3. Marr, L.C., Kirchstetter, T.W., and Harley, R.A. (1999) Characterization of polycyclic aromatic hydrocarbons in motor vehicle fuels and exhaust emissions. Environ. Sci. Technol., 33, 3091-3099.
4. Lijinsky, W. and Ross, A.E. (1967) Production of carcinogenic polynuclear hydrocarbons in the cooking of food. Food Cosmet. Toxicol., 5, 343-347.
5. Doremire, M.E., Harmon, G.E., and Pratt, D.E. (1979) 3,4-Benzopyrene in charcoal grilled meats. J. Food Sci., 44, 622-623.
6. Hecht, S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst., 91, 1194-1210.
7. Dipple, A. (1984) Polycyclic aromatic hydrocarbon carcinogenesis: an introduction, in Polycyclic Hydrocarbons and Carcinogenesis (ed. R.G. Harvey), American Chemical Society, Washington, DC, pp. 1-18.
8. Lehr, R.E., Kumar, S., Levin, W., Wood, A.W., Chang, R.L., Conney, A.H., Yagi, H., Sayer, J.M., and Jerina, D.M. (1985) The bay-region theory of polycyclic aromatic hydrocarbon carcinogenesis, in Polycyclic Hydrocarbons and Carcinogenesis (ed. R.G. Harvey), American Chemical Society, Washington, DC, pp. 63-84.
9. Hecht, S.S., Amin, S., Melkikian, A.A., LaVoie, E.J., and Hoffmann, D. (1985) Effects of methyl and fluorine substitution on the metabolic activation and tumorigenicity of polycyclic aromatic hydrocarbons, in Polycyclic Hydrocarbons and Carcinogenesis (ed. R.G. Harvey), American Chemical Society, Washington, DC, pp. 85-105.
10. Cavalieri, E.L., Higginbotham, S., RamaKrishna, N.V.S., Devanesan, P.D., Todorovic, R., Rogan, E.G., and Salmasi, S. (1991) Comparative dose-response tumorigenicity studies of dibenzo[a, l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a, l] pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis, 12, 1939-1944.
11. Cavalieri, E.L. and Rogan, E.G. (1995) Central role of radical cations in the metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica, 25, 677-688.
12. Gelboin, H.V. (1980) Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed function oxidases and related enzymes. Physiol. Rev., 60, 1107-1166.
13. Conney, A.H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res., 42, 4875-4917.
14. Shimada, T., Martin, M.V., Pruess-Schwartz, D., Marnett, L.J., and Guengerich, F.P. (1989) Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo[a] pyrene, 7,8-dihydroxy-7,8-dihydrobenzo [a]pyrene and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res., 49, 6304-6312.
15. Shimada, T., Hayes, C.L., Yamazaki, H., Amin, S., Hecht, S.S., Guengerich, F.P., and Sutter, T.R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res., 56, 2979-2984.
16. Shimada, T., Yamazaki, H., Mimura, M., Wakamiya, N., Ueng, Y.-F., Guengerich, F.P., and Inui, I. (1996) Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab. Dispos., 24, 515-522.
17. Penning, T.M., Burczynski, M.E., Hung, C.-F., McCoull, K.D., Palackal, N.T., and Tsuruda, L.S. (1999) Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox-active o-quinones. Chem. Res. Toxicol., 12, 1-18.
18. Burczynski, M.E., Harvey, R.G., and Penning, T.M. (1998) Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a] pyrene-7,8-dione. Biochemistry, 37, 6781-6790.
19. Palackal, N.T., Burczynski, M.E., Harvey, R.G., and Penning, T.M. (2001) The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation. Biochemistry, 40, 10901-10910.
20. Palackal, N.T., Lee, S.H., Harvey, R.G., Blair, I.A., and Penning, T.M. (2002) Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung adenocarcinoma (A549) cells. J. Biol. Chem., 277, 24799-24808.
21. Yamamoto, F. and Perucho, M. (1984) Activation of human c-K-ras oncogene. Nucleic Acid Res., 12, 8873-8885.
22. Rodenhuis, S. and Siebos, R.J. (1990) The ras oncogenes in human lung cancer. Am. Rev. Respir. Dis., 142, S27-S30.
23. Capella, G., Cronauer-Mitra, S., Pienado, M.A., and Perucho, M. (1991) Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ. Health Perspect., 93, 125-131.
24. Top, B., Mooj, W.J., Klaver, S.G., Berrigter, L., Wisman, P., Elbers, H.R., Viser, S., and Rodenhuis, S. (1995) Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer. Int. J. Cancer, 64, 83-91.
25. Gealy, R., Zhang, L., Siegfried, J.M., Luketich, J.D., and Keohavong, P. (1999) Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and non-smoking women. Cancer Epidemiol. Biomarkers Prev., 8, 297-302.
26. Vahakanga, K.H., Bennett, W.P., Castren, K., Welsh, J.A., Khan, M.A., Bjomek, B., Alavanja, M.C., and Harris, C.C. (2001) p53 and K-ras mutations in lung cancers from former and never smoking women. Cancer Res., 61, 4350-4356.
27. Lorentzen, R.J., Caspary, W.J., Lesko, S.A., and Ts'o, P.O.P. (1975) The autoxidation of 6-hydroxybenzo[a]pyrene and 6-oxobenzo[a]pyrene radical, reactive metabolites of benzo[a]pyrene. Biochemistry, 14, 3970-3977.
28. Devanesan, P.D., Rama-Krishna, N.V.S., Todorovic, R., Rogan, E.G., Cavalieri, E.L., Jeong, H., Jankowiak, R., and Small, G.J. (1992) Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem. Res. Toxicol., 5, 302-309.
29. Devanesan, P.D., Higginbotham, S., Ariese, F., Jankowiak, R., Suh, M., Small, G.J., Cavalieri, E., and Rogan, E. (1996) Depurinating and stable benzo[a] pyrene-DNA adducts formed in isolated rat liver nuclei. Chem. Res. Toxicol., 9, 1113-1116.
30. RamaKrishna, N.V.S., Devanesan, P.D., Rogan, E.G., Cavalieri, E.L., Jeong, H., Jankowiak, R., and Small, G.J. (1992) Mechanism of metabolic activation of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Chem. Res. Toxicol., 5, 220-226.
31. Li, K.-M., Todorovic, R., Rogan, E.G., Cavalieri, E.L., Ariese, F., Suh, M., Jankowiak, R., and Small, G.J. (1995) Identification and quantitation of dibenz[a, l]pyrene-DNA adducts formed by rat liver microsomes in vitro : preponderance of depurinating DNA adducts. Biochemistry, 34, 8043-8049.
32. Chen, L., Devanesan, P.D., Higginbotham, S., Ariese, F., Jankowiak, R., Small, G.J., Rogan, E.G., and Cavalieri, E. (1996) Expanded analysis of benzo[a] pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. Chem. Res. Toxicol., 9, 897-903.
33. Cavalieri, E.L., Rogan, E.L., Li, K.-M., Todorovic, R., Ariese, F., Jankowiak, R., Grubor, N., and Small, G.J. (2005) Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a, l] pyrene (DB[a, l]P) or its metabolites and in rat mammary gland treated with DB[a, l]P. Chem. Res. Toxicol., 18, 976-983.
34. Sagher, D. and Strauss, B. (1983) Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis. Uniqueness of adenine nucleotides. Biochemistry, 22, 4518-4526.
35. Wilson, D.M. and Barsky, D. (2001) The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat. Res., 485, 283-307.
36. Chakravarti, D., Pelling, J.C., Cavalieri, E.L., and Rogan, E.G. (1995) Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras-mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl. Acad. Sci. USA, 92, 10422-10426.
37. Casale, G.P., Singhal, M., Bhattacharya, S., RamaNathan, R., Roberts, K.P., Barbaccia, D.C., Zhao, J., Jankowiak, R., Gross, M.L., Cavalieri, E.L., Smith, G.J., Reannard, S.I., Mumford, J.L., and Shen, M. (2001) Detection and quantitation of depurinated benzo[a] pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem. Res. Toxicol., 14, 192-201.
38. Nakamura, J., Walker, V.E., Upton, P.B., Chiang, S.Y., Kow, Y.W., and Swenberg, J.A. (1998) Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res., 58, 222-225.
39. Nakamura, J. and Swenberg, J.A. (1999) Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res., 59, 2522-2526.
40. MelendezColon, V.J., Smith, C.A., Seidel, A., Luch, A., Platt, K.L., and Baird, W.M. (1997) Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a, l] pyrene or its diol-epoxides. Proc. Natl. Acad. Sci. USA, 94, 13542-13547.
41. Melendez-Colon, V.J., Luch, A., Siedel, A., and Baird, W.M. (1999) Comparison of cytochrome P450-and peroxidase-dependent metabolic activation of the potent carcinogen dibenzo[a, l]pyrene in human cell lines: formation of stable DNA adducts and absence of a detectable increase in apurinic sites. Cancer Res., 59, 1412-1426.
42. Melendez-Colon, V.J., Luch, A., Seidel, A., and Baird, W.M. (2000) Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures. Chem. Res. Toxicol., 13, 10-17.
43. De Bont, R. and van Larebeke, N. (2004) Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis, 19, 169-185.
44. Denison, M.S., Fisher, J.M., and Whitlock, J.P. Jr. (1988) The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. J. Biol. Chem., 263, 17221-17224.
45. Sutter, T.R., Tang, Y.M., Hayes, C.L., Wo, Y.-Y.P., Jabs, W., Li, X., Yin, H., Cody, C.W., and Greenlee, W.F. (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269, 13092-13099.
46. Nordqvist, M., Thakker, D.R., Vyas, K.P., Yagi, H., Levin, W., Ryan, D.E., Thomas, P.E., Conney, A.H., and Jerina, D.M. (1981) Metabolism of chrysene and phenanthrene to bay region diol-epoxides by rat liver enzymes. Mol. Pharmacol., 19, 168-178.
47. Wood, A.W., Levin, W., Ryan, D., Thomas, P.E., Yagi, H., Mah, H.D., Thakker, D.R., Jerina, D.M., and Conney, A.H. (1977) High mutagenicity of metabolically activated chrysene-1,2-dihydrodiol. Evidence for bay region activation of chrysene. Biophys. Res. Commun., 78, 847-854.
48. Levin, W., Thakker, D.R., Wood, A.W., Chang, R.L., Lehr, R.E., Jerina, D.M., and Conney, A.H. (1978) Evidence that benz[a]anthracene-3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin. Cancer Res., 38, 1705-1710.
49. Melikian, A.A., LaVoie, E.J., Hecht, S.S., and Hoffmann, D. (1982) Influence of a bay-region methyl group on formation of 5-methyl-chrysene dihydrodiol epoxide: DNA adducts in mouse skin. Cancer Res., 42, 1239-1242.
50. Slaga, T.J., Gleason, G.L., DiGiovanni, J., Sukumaran, K.B., and Harvey, R.G. (1979) Potent tumor initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz[a]anthracene in mouse skin. Cancer Res., 39, 1934-1936.
51. Agarwal, R., Coffing, S.L., Baird, W.M., Kiselyov, A.S., Harvey, R.G., and Dipple, A. (1997) Metabolic activation of benzo[g]chrysene in the human mammary carcinoma cell line MCF-7. Cancer Res., 57, 415-419.
52. Shukla, R., Jelinsky, S., Liu, T., Geactinov, N.E., and Loechler, E.L. (1997) How stereochemistry affects mutagenesis by N 2-deoxyguanosine adducts of 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene: configuration of the adduct bond is more important than those of hydroxyl groups. Biochemistry, 36, 13263-132639.
53. Zhang, N., Lin, C., Huang, X., Kolbanovskiy, A., Hingerty, B.E., Amin, S., Broyde, S., Geactinov, N.E., and Patel, D.J. (2005) Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol-epoxide-N 2-guanine adduct in DNA from a minor grove alignment to intercalation with base displacement. J. Mol. Biol., 346, 951-965.
54. Jennette, K.W., Jeffery, A.M., Blobstein, S.H., Beland, F.A., Harvey, R.G., and Weinstein, I.B. (1977) Nucleoside adducts from the in vitro reaction of benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide or benzo[a]pyrene-4,5-oxide with nucleic acids. Biochemistry, 16, 932-938.
55. Smolarek, T.A. and Baird, W.M. (1984) Benzo[a]pyrene-induced alterations in the binding of benzo[a]pyrene to DNA in hamster embryo cell cultures. Carcinogenesis, 5, 1065-1069.
56. Baird, W.M., Lau, H.H., Schmerold, I., Cofing, S.L., Brozich, S.L., Lee, H., and Harvey, R.G. (1993) Analysis of polycyclic aromatic hydrocarbon-DNA adducts by post-labeling with the β-emittters 35 S-phosphorothioate and 32 P-phosphate, immobilized boronate chromatography and high performance liquid chromatography. IARC Sci. Publ., 124, 217-226.
57. Kleiner, H.E., Reed, M.J., and DiGiovanni, J. (2003) Naturally occurring coumarins inhibit human cytochrome P450 and block benzo[a] pyrene and 7,12-dimethylbenz[a] anthracene DNA adduct formation in MCF-7 cells. Chem. Res. Toxicol., 16, 415-422.
58. Ruan, Q., Kim, H.-Y.H., Jiang, H., Penning, T.M., Harvey, R.G., and Blair, I.A. (2006) Quantification of benzo[a] pyrene diol epoxide DNA-adducts by stable isotope dilution liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom., 20, 1369-1380.
59. Ruan, Q., Gelhaus, S.L., Penning, T.M., Harvey, R.G., and Blair, I.A. (2007) Aldo-keto reductase-and cytochrome P450-dependent formation of benzo[a] pyrene-derived DNA adducts in human bronchoalveolar cells. Chem. Res. Toxicol, 20, 424-431.
60. Koreeda, M., Moore, P.D., Wislocki, P.G., Levin, W., Conney, A.H., Yagi, H., and Jerina, D.M. (1978) Binding of benzo[a]pyrene-7,8-diol-9,10-epoxides to DNA, RNA and protein of mouse skin occurs with high stereoselectivity. Science, 199, 778-781.
61. Nesnow, S., Ross, J.A., Mass, M.J., and Stoner, G.D. (1998) Mechanistic relationships between DNA adducts, oncogene mutations and lung tumorigenesis in strain A mice. Exp. Lung Res., 24, 395-495.
62. Motoykiewicz, G., Malusecka, E., Grzybowska, E., Chorazy, M., Zhang, Y.J., Perera, F.P., and Santella, R.M. (1995) Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes. Cancer Res., 55, 1417-1422.
63. Reddy, M., Gupta, R.C., Randerath, E., and Randerath, K. (1984) 32 P-Post-labeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis, 5, 231-243.
64. Santella, R.M., Yang, X.Y., Hsieh, L.L., and Young, T.L. (1990) Immunologic methods for the detection of carcinogen DNA adducts in humans. Prog. Clin. Res., 340C, 247-257.
65. Pavanello, S., Favretto, D., Brugnone, F., Mastrangelo, G., Pra, G.D., and Clonfero, E. (1999) HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis, 20, 431-435.
66. Hecht, S., Chen, M., Yagi, H., Jerina, D.M., and Carmella, S.G. (2003) r-1, t-2,3, c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. Cancer Epidemiol. Biomarkers Prev. Res., 12, 1501-1508.
67. Beland, F.A., Churchwell, M.L., Von Tungeln, L.S., Che, S., Fu, P.P., Culp, S.J., Schoket, B., Gyorffy, E., Mianarovits, J., Poirier, M.C., Bowman, E.D., Weston, A., and Doergee, D.R. (2005) High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts. Chem. Res. Toxicol., 18, 1306-1315.
68. Malaveille, C., Kuroki, T., Sims, P., Grover, P.L., and Bartsch, H. (1977) Mutagenicity of isomeric diol-epoxides of benzo[a]pyrene and benz[a] anthracene in S. typhimurium TA98 and TA100 and in V79 Chinese hamster cells. Mutat. Res., 44, 313-326.
69. Kapitulnik, J., Wislocki, P.G., Levin, W., Yagi, H., Jerina, D.M., and Conney, A.H. (1978) Tumorigenicity studies with diol-epoxides of benzo[a]pyrene which indicate that (+)-trans-7 β,8 α-dihydroxy-9 α,10 α-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene is an ultimate carcinogen in newborn mice. Cancer Res., 38, 354-358.
70. Marshall, C.J., Vousden, K.H., and Phillips, D.H. (1984) Activation of c-Ha-ras-1 proto-oncogene by in vitro chemical modification with a chemical carcinogen, benzo[a]pyrene diol-epoxide. Nature, 310, 585-589.
71. Denissenko, M.F., Pao, A., Tang, M.-S., and Pfieifer, G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
72. Hanawalt, P.C., Ford, J.M., and Lloyd, D.R. (2003) Functional characterization of global genomic DNA repair and its implications for cancer. Mutat. Res., 54, 107-114.
73. Fousterri, M. and Mullenders, L.H. (2008) Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res., 18, 73-84.
74. McCulloch, S.D. and Kunkel, T.A. (2008) The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res., 18, 148-161.
75. Yang, W. and Woodgate, R. (2007) What a difference a decade makes: insights into translesion DNA synthesis. Proc. Natl. Acad. Sci. USA, 104, 15591-15598.
76. Zhao, B., Wang, J., Geactinov, N.E., and Wang, Z. (2006) Pol η, pol ζ and Rev1 together are required for G to T transversion mutations induced by the (+)-and (-)-trans-anti-BPDE-N 2-dG DNA adducts in yeast cells. Nucleic Acid Res., 34, 417-425.
77. Schcahar, S., Ziv, O., Avkin, S., Adar, S., Wittschieben, J., Reibner, T., Chaney, S., Friedberg, E.C., Wang, Z., Carell, T., Geacintov, N., and Lineh, Z. (2009) Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals. EMBO J., 28, 383-393.
78. Uno, S., Dalton, T.P., Shertzer, H.G., Genter, M.B., Warshawsky, D., Talaska, G., and Nebert, D.W. (2001) Benzo[a] pyrene-induced toxicity: paradoxical protection in Cyp1a1-/-knockout mice having increased hepatic B[a]P-DNA adduct levels. Biochem. Biophys. Res. Commun., 289, 1049-1056.
79. Uno, S., Dalton, T.P., Derkenne, S., Curran, C.P., Miller, M.L., Shertzer, H.G., and Nebert, D.W. (2004) Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol. Pharmacol., 65, 1225-1237.
80. Uno, S., Dalton, T.P., Dragin, N., Curran, C.P., Derkenne, S., Miller, M.L., Shertzer, H.G., Gonzalez, F.J., and Nebert, D.W. (2006) Oral benzo[a] pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total body burden and clearance rate. Mol. Pharmacol., 69, 1103-1114.
81. Frenkel, K. (1992) Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther., 53, 127-166.
82. Frenkel, K., Wei, L., and Wei, H. (1995) 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic. Biol. Med., 19, 373-380.
83. Quinn, A., Harvey, R.G., and Penning, T.M. (2008) Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10. Chem. Res. Toxicol., 21, 2207-2215.
84. Smithgall, T.E., Harvey, R.G., and Penning, T.M. (1988) Spectroscopic identification of ortho-quinones as the products of polycyclic aromatic trans-dihydrodiol oxidation catalyzed by dihydrodiol dehydrogenase. A potential route of proximate carcinogen metabolism. J. Biol. Chem., 263, 1814-1820.
85. Penning, T.M., Ohnishi, S.T., Ohnishi, T., and Harvey, R.G. (1996) Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem. Res. Toxicol., 9, 84-92.
86. Flowers-Geary, L., Harvey, R.G., and Penning, T.M. (1992) Examination of polycyclic aromatic hydrocarbon o-quinones produced by dihydrodiol dehydrogenase as substrates for redox-cycling in rat liver. Biochem. (Life. Sci. Adv.), 11, 49-58.
87. Flowers-Geary, L., Harvey, R.G., and Penning, T.M. (1993) Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells. Chem. Res. Toxicol., 6, 252-260.
88. Flowers-Geary, L., Bleczinski, W., Harvey, R.G., and Penning, T.M. (1996) Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon o-quinones produced by dihydrodiol dehydrogenase. Chem. Biol. Inter., 99, 55-72.
89. Bolton, J.L., Psiha, E., Zhang, F., and Qiu, S. (1998) Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol., 11, 13-27.
90. Zhang, F., Chen, Y., Pisha, E., Shen, L., Xiong, Y., van Breeman, R.B., and Bolton, J.L. (1999) The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin o-quinone. Chem. Res. Toxicol., 12, 204-213.
91. Zhang, F., Swanson, S.M., van Breemen, R.B., Liu, X., Yang, Y., Gu, C., and Bolton, J.L. (2001) Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in rat mammary tissues: formation of single-strand breaks, apurinic sites and stable adducts and oxidized bases. Chem. Res. Toxicol., 14, 1654-1659.
92. Cavalieri, E.L. and Rogan, E.G. (2004) A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. A nn. NY Acad. Sci., 1028, 247-257.
93. Yue, W., Santen, R.J., Wang, J.P., Li, Y., Verdearme, M.F., Bocchinfuso, W.P., Korach, K.S., Devanesan, P., Todorovic, R., Rogan, E.G., and Cavalieri, E.L. (2003) Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J. Steroid Biochem. Mol. Biol., 86, 477-486.
94. Shou, M., Harvey, R.G., and Penning, T.M. (1993) Reactivity of benzo[a] pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis, 14, 475-482.
95. Balu, N., Padgett, W.T., Lambert, G.R., Swank, A.E., Richard, A.M., and Nesnow, S. (2004) Identification and characterization of novel stable deoxyguanosine and deoxyadenosine adducts of benzo[a]pyrene-7,8-quinone from reactions at physiological pH. Chem. Res. Toxicol., 17, 827-838.
96. Balu, N., Padgett, W.T., Nelson, G.B., Lambert, G.R., Ross, J.A., and Nesnow, S. (2006) Benzo[a]pyrene-7,8-quinone-3 ′-mononucleotide adduct standards for 32 P post-labeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts. Anal. Biochem., 355, 213-223.
97. McCoull, K.D., Rindgen, D., Blair, I.A., and Penning, T.M. (1999) Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. Chem. Res. Toxicol., 12, 237-246.
98. Yu, D., Berlin, J.A., Penning, T.M., and Field, J.M. (2002) Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem. Res. Toxicol., 15, 832-842.
99. Shen, Y., Troxel, A.B., Vedantam, S., Penning, T.M., and Field, J.M. (2006) Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene-diol-epoxide in vitro : role of reactive oxygen and biological selection. Chem. Res. Toxicol., 19, 1441-1450.
100. Park, J.-H., Gelhaus, S., Vedantam, S., Olivia, A., Batra, A., Blair, I.A., Field, J., and Penning, T.M. (2008) The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance. Chem. Res. Toxicol., 21, 1039-1049.
101. Breen, A.P. and Murphy, J.P. (1995) Reactions of oxyl radicals with DNA. Free Radic. Biol. Med., 18, 1033-1077.
102. Park, J.-H., Gopishetty, S., Szewczuk, L.M., Troxel, A.B., Harvey, R.G., and Penning, T.M. (2005) Formation of 8-oxo-7,8-dihydro-2 ′-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling. Chem. Res. Toxicol., 18, 1026-1037.
103. Flowers, L., Ohnishi, S.T., and Penning, T.M. (1997) DNA strand scission by polycyclic aromatic hydrocarbon o-quinones: role of reactive oxygen species Cu(II)/Cu(I) redox cycling, and o-semiquinone anion radicals. Biochemistry, 36, 8640-8648.
104. Park, J.-H., Troxel, A.B., Harvey, R.G., and Penning, T.M. (2006) Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the aldo-keto reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species. Chem. Res. Toxicol., 19, 719-728.
105. Park, J.H., Mangal, D., Tacka, K.A., Quinn, A.M., Harvey, R.G., Blair, I.A., and Penning, T.M. (2008) Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells. Proc. Natl. Acad. Sci. USA, 105, 6846-6851.
106. Mangal, D., Vudathala, D., Park, J.-H., Lee, S.H., Penning, T.M., and Blair, I.A. (2009) Analysis of 7,8-dihydro-8-oxo-2 ′-deoxyguanosine in cellular DNA during oxidative stress. Chem. Res. Toxicol., 788-797.
107. Shibutani, S., Takeshita, M., and Grollman, A.P. (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxo-dG. Nature, 349, 431-434.
108. Henderson, P.T., Delaney, J.C., Gu, F., Tannenbuam, S.R., and Essigmann, J.M. (2002) Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry, 41, 914-921.
109. Zharkov, D.O. (2008) Base excision DNA repair. Cell. Mol. Life Sci., 65, 1544-1565.
110. Fromme, J., Banerjee, A., Huang, S.J., and Verdine, G.L. (2004) Structural basis for removal of adenine mispaired with 8-oxoguanine by MutY adenine DNA glycosylase. Nature, 427, 652-656.
111. Lu, R., Nash, H.M., and Verdine, G.L. (1997) A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer. Curr. Biol., 7, 397-407.
112. Chevillard, S., Radicella, J.P., Levalois, C., Lebeau, J., Poupon, M.F., Oudard, S., Dutrillaux, B., and Boiteux, S. (1998) Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumors. Oncogene, 16, 3083-3086.
113. Wikman, H., Risch, A., Klimek, F., Schmezer, P., Spiegelhalder, B., Dienemann, H., Kayser, K., Schulz, V., Drings, P., and Bartsch, H. (2000) hOOG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a Caucasian population. Int. J. Cancer, 88, 932-937.
114. Zhou, X., Taghizadeh, K., and Dedon, P.C. (2005) Chemical and biological evidence for base propenals as the major source of the endogenous M 1 dG adduct in cellular DNA. J. Biol. Chem., 280, 25377-25382.
115. Blair, I.A. (2008) DNA adducts with lipid peroxidation products. J. Biol. Chem., 283, 15545-15549.
116. Luo, W., Muller, J.G., Rachin, E.M., and Burrows, C.J. (2000) Charac terization of spiroiminodihydantoin as a product of one-electron oxidation of 8-oxo-7,8-dihydroguanosine. Org. Lett., 2, 613-616.
117. Ye, Y., Muller, J.G., Luo, W., Mayne, C.L., Shallop, A.J., Jones, R.A., and Burrows, C.J. (2003) Formation of 13 C, 15 N, and 18 O-labeled guandinohydantoin from guanosine oxidation with singlet oxygen. Implications for structure and mechanism. J. Am. Chem. Soc., 125, 13926-13927.
118. Smithgall, T.E., Harvey, R.G., and Penning, T.M. (1986) Regio-and stereospecificity of homogeneous 3 α-hydroxysteroid/dihydrodiol dehydrogenase for trans-dihydrodiol metabolites of polycyclic aromatic hydrocarbons. J. Biol. Chem., 261, 6184-6191.